✦ LIBER ✦

Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma

✍ Scribed by Martin Kropff; Guido Bisping; Elke Schuck; Peter Liebisch; Nicola Lang; Markus Hentrich; Tobias Dechow; Nicolaus Kröger; Hans Salwender; Bernd Metzner; Orhan Sezer; Monika Engelhardt; Hans-Heinrich Wolf; Hermann Einsele; Sarah Volpert; Achim Heinecke; Wolfgang E. Berdel; Joachim Kienast; on behalf of the Deutsche Studiengruppe Multiples Myelom; DSMM

Book ID: 108675285
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 549 KB
Volume: 138
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2007.06656.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bortezomib, low-dose intravenous melphal

Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma

✍ Rakesh Popat; Heather Oakervee; Catherine Williams; Mark Cook; Charles Craddock; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Continuous low-dose dexamethasone in rel

Continuous low-dose dexamethasone in relapsed or refractory multiple myeloma

✍ C. W. Tiplady; G. P. Summerfield 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

A phase I study of bortezomib in combina

A phase I study of bortezomib in combination with doxorubicin and intermediate-dose dexamethasone (iPAD therapy) for relapsed or refractory multiple myeloma

✍ Yasushi Takamatsu; Kazutaka Sunami; Hiroyuki Hata; Koji Nagafuji; Ilseung Choi; 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 167 KB

Low-dose thalidomide in combination with

Low-dose thalidomide in combination with oral weekly cyclophosphamide and pulsed dexamethasone is a well tolerated and effective regimen in patients with relapsed and refractory multiple myeloma

✍ Charalampia Kyriakou; Kirsty Thomson; Shirley D'Sa; Angela Flory; Judith Hanslip 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Bortezomib plus intermediate-dose dexame

Bortezomib plus intermediate-dose dexamethasone and thalidomide in elderly untreated patients with multiple myeloma: A Chinese experience

✍ Hongfeng Guo; Xin Zhou; Yuanqiang Jiang; Guohua Yang; Chao Sun; Yun Zhuang; Hong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

DSMM XI study: dose definition for intra

DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed myeloma

✍ Martin Kropff; Peter Liebisch; Stefan Knop; Katja Weisel; Hannes Wand; Claudia-N 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 125 KB